INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

11229	Companies
249031	Keywords
176866	Articles
134818	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 9 months ago

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
Inventiva publie son bilan semestriel du contrat de liquidité avec Kepler Cheuvreux. Espèces de 349 630,55 € et 113 452 actions Inventiva au 31/12/2024. Analyse des transactions du semestre. Entreprise biopharmaceutique axée sur la stéatohépatite et autres maladies

Contrat De Liquidité Bilan Semestriel Kepler Cheuvreux Biopharmaceutique Inventiva
PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 9 months ago

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva announces half-year liquidity contract review with Kepler Cheuvreux. Cash and shares available in the liquidity account disclosed. Company focuses on developing oral small molecule therapies for MASH and unmet medical needs

Liquidity Contract Kepler Cheuvreux Clinical-Stage Biopharmaceutical Inventiva MASH
BRIEF

published on 01/22/2025 at 22:05, 1 year 9 months ago

Inventiva's LEGEND Trial Results to be Presented at EASL SLD Summit 2025

Lanifibranor Empagliflozin LEGEND Trial MASH Treatment EASL Summit 2025
BRIEF

published on 01/22/2025 at 22:05, 1 year 9 months ago

Les résultats de l'essai LEGEND d'Inventiva seront présentés au sommet EASL SLD 2025

Lanifibranor Empagliflozine Essai De LEGEND Traitement MASH Sommet EASL 2025
PRESS RELEASE

published on 01/22/2025 at 22:00, 1 year 9 months ago

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D

Inventiva MASH Lanifibranor Empagliflozin LEGEND Trial
PRESS RELEASE

published on 01/22/2025 at 22:00, 1 year 9 months ago

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025
Les résultats de LEGEND sur la combinaison de lanifibranor avec empagliflozine pour la MASH seront présentés au EASL SLD Summit 2025. Améliorations métaboliques et sécurité démontrées

MASH Lanifibranor Empagliflozine LEGEND EASL SLD Summit
BRIEF

published on 12/17/2024 at 22:05, 1 year 10 months ago

Inventiva présente à la J.P. Morgan Healthcare Conference

Investisseurs Inventiva NASH Lanifibranor J.P. Morgan Healthcare
BRIEF

published on 12/17/2024 at 22:05, 1 year 10 months ago

Inventiva to present at the JP Morgan Healthcare Conference

Investors Inventiva NASH Lanifibranor JP Morgan Healthcare
PRESS RELEASE

published on 12/17/2024 at 22:00, 1 year 10 months ago

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference »
Inventiva annonce sa participation à la 43rd Annual J.P. Morgan Healthcare Conference. Frédéric Cren présentera les activités de la Société le 15 janvier 2025 à San Francisco

Biopharmaceutique Inventiva MASH/NASH J.P. Morgan Healthcare Conference Frédéric Cren
PRESS RELEASE

published on 12/17/2024 at 22:00, 1 year 10 months ago

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference with CEO Frédéric Cren providing a corporate overview and engaging in investor meetings

Biopharmaceutical Inventiva J.P. Morgan Healthcare Conference Frédéric Cren Metabolic Dysfunction

Accesswire

Published on 10/26/2026 at 13:30, 20 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Conference Call and Webcast Date
Published on 10/26/2026 at 13:00, 50 minutes ago

BTU Commences Initial Drill Program on Hubcap Project Adjacent to RPX in Wawa
Published on 10/26/2026 at 13:00, 50 minutes ago

GameSquare Closes FanEngine Transaction
Published on 10/26/2026 at 12:30, 1 hour 20 minutes ago

Longview Capital Announces Voluntary TSXV Delisting
Published on 10/26/2026 at 12:30, 1 hour 20 minutes ago

Empress Appoints Chief Investment Officer and Strengthens Senior Leadership Team

View all ACCESSWIRE

EQS Group

Published on 10/26/2026 at 13:35, 14 minutes ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.05 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $15 Billion
Published on 10/26/2026 at 12:22, 1 hour 27 minutes ago

Issue of Equity
Published on 10/26/2026 at 12:05, 1 hour 44 minutes ago

EQS-Adhoc: Notification regarding the selection of an auditor of Starcom Holding AD for 2026
Published on 10/26/2026 at 12:00, 1 hour 49 minutes ago

OHB acquires stake in MediaMobil to strengthen satellite communications capabilities
Published on 10/26/2026 at 11:30, 2 hours 19 minutes ago

Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): Buy

Les Echos

Published on 10/26/2026 at 11:27, 2 hours 22 minutes ago

261026 BENETEAU Transactions sur actions propres
Published on 10/26/2026 at 07:30, 6 hours 20 minutes ago

EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/26/2026 at 07:30, 6 hours 20 minutes ago

LE CONSEIL DE SURVEILLANCE D’EURAZEO NOMME M. CHRISTOPHE BAVIERE PRESIDENT DU DIRECTOIRE
Published on 10/23/2026 at 20:33, 2 days 17 hours ago

Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026
Published on 10/23/2026 at 20:33, 2 days 17 hours ago

Disclosure of transactions in own shares from October 19 to October 23, 2026

View all LES ECHOS COMFI WIRE